Upregulation of TUBB3 expression can destabilize microtubules and inhibit taxanes [7], which has been confirmed in various types of cancer, including breast cancer [22,23], lung cancer, ovarian cancer, prostate cancer, stomach cancer, and pancreatic cancer [24]. Here, TUBB3 is linked to prostate carcinoma.